New hope for advanced tumors? first human trial launches
Disease control
Recruiting now
This is a first-in-human study testing a new drug called AT03-65 in adults with advanced solid tumors that have not responded to standard treatments. The main goal is to find a safe dose and understand side effects. About 83 participants will take part in this early-phase trial.
Phase: PHASE1 • Sponsor: Axcynsis Therapeutics Pte Ltd • Aim: Disease control
Last updated May 11, 2026 20:41 UTC